Risk for peri-implant diseases and defects: Report of workgroup 1 of the joint AO/AAP consensus conference on prevention and management of peri-implant diseases
Purnima S. Kumar, Joseph Kan, Maria Elisa Galarraga-Vinueza, Guo-Hao Lin, Alberto Monje, Lorenzo Tavelli, Sandra Stuhr, Yung-Ting Hsu, Junying Li, Alexandra Tsigarida, Debora Dias, SukirthMurthy Ganesan, Shi Yin, Don Curtis
{"title":"Risk for peri-implant diseases and defects: Report of workgroup 1 of the joint AO/AAP consensus conference on prevention and management of peri-implant diseases","authors":"Purnima S. Kumar, Joseph Kan, Maria Elisa Galarraga-Vinueza, Guo-Hao Lin, Alberto Monje, Lorenzo Tavelli, Sandra Stuhr, Yung-Ting Hsu, Junying Li, Alexandra Tsigarida, Debora Dias, SukirthMurthy Ganesan, Shi Yin, Don Curtis","doi":"10.1002/cap.10367","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>A consensus meeting on peri-implant diseases and treatment was initiated by the American Academy of Periodontology (AAP) and the Academy of Osseointegration (AO) with the goal of developing subject- and site-level risk profiles for peri-implant diseases and defects, and risk-informed treatment recommendations. This report summarizes the conclusions of Working Group 1.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Working Group 1 evaluated the risk for peri-implant diseases and defects based on four commissioned systematic reviews, followed by an in-person workshop to discuss the reviews and the inferences.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Several factors emerged as risk markers for peri-implant mucositis, peri-implantitis, as well as for soft and hard tissue discrepancies and defects in the absence of disease.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Patient- and site-level factors can increase the odds of developing peri-implant disease or defects in soft tissue and marginal bone surrounding clinically healthy implants. Risk-informed treatment recommendations were made by the panel of experts.</p>\n </section>\n \n <section>\n \n <h3> Key points</h3>\n \n <div>\n <ul>\n \n <li>This consensus estimates risk based on both patient and site-level factors.</li>\n \n <li>Consideration must be given to modifiable and non-modifiable risk factors, and treatment modified accordingly.</li>\n \n <li>There is a lack of primary research on several topics that were considered by the consensus panel, and several gaps in knowledge still continue to exist.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":55950,"journal":{"name":"Clinical Advances in Periodontics","volume":"15 2","pages":"93-102"},"PeriodicalIF":0.9000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cap.10367","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Advances in Periodontics","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cap.10367","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Background
A consensus meeting on peri-implant diseases and treatment was initiated by the American Academy of Periodontology (AAP) and the Academy of Osseointegration (AO) with the goal of developing subject- and site-level risk profiles for peri-implant diseases and defects, and risk-informed treatment recommendations. This report summarizes the conclusions of Working Group 1.
Methods
Working Group 1 evaluated the risk for peri-implant diseases and defects based on four commissioned systematic reviews, followed by an in-person workshop to discuss the reviews and the inferences.
Results
Several factors emerged as risk markers for peri-implant mucositis, peri-implantitis, as well as for soft and hard tissue discrepancies and defects in the absence of disease.
Conclusion
Patient- and site-level factors can increase the odds of developing peri-implant disease or defects in soft tissue and marginal bone surrounding clinically healthy implants. Risk-informed treatment recommendations were made by the panel of experts.
Key points
This consensus estimates risk based on both patient and site-level factors.
Consideration must be given to modifiable and non-modifiable risk factors, and treatment modified accordingly.
There is a lack of primary research on several topics that were considered by the consensus panel, and several gaps in knowledge still continue to exist.